A Compounding Pharmacy Government Affairs Podcast. Informing both 503A and 503B compounders on the ever-changing political landscape. MEDISCA has actively solidified its role as a leader in the industry, not only for innovation and quality, but for playing an instrumental role in the advancement of compounding related issues before the FDA. The goal of the Pharmacy Legislative Advocacy Group (PhLAG) is simple, to ensure that every Pharmacy/Outsourcing Facility has a platform to learn, participate, and be heard. PhLAG and MEDISCA want to help traditional compounding pharmacies, as well as outsourcing facilities, navigate these imperative issues.